J. Pardos-Gea

发表

Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review

A. Selva-O'Callaghan, J. Alijotas-Reig, A. Mékinian, 2020, Autoimmunity Reviews.

Bleeding and antithrombotic therapy during pregnancy in women with poor aPL-related obstetric outcomes

G. Espinosa, A. Tincani, J. Alijotas-Reig, 2021, European journal of anaesthesiology.

Autoantibodies to types I and IV collagen and heart valve disease in systemic lupus erythematosus/antiphospholipid syndrome

J. Castro-Marrero, E. Balada, J. Ordi‐Ros, 2017, Clinical Rheumatology.

Cardiac manifestations other than valvulopathy in antiphospholipid syndrome: long‐time echocardiography follow‐up study

A. Evangelista, M. Vilardell, J. Ordi‐Ros, 2015, International journal of rheumatic diseases.

Echocardiography at diagnosis of antiphospholipid syndrome provides prognostic information on valvular disease evolution and identifies two subtypes of patients

A. Evangelista, M. Vilardell, M. Vilardell, 2010, Lupus.

Persistent thrombocytopenia predicts poor long-term survival in patients with antiphospholipid syndrome: a 38-year follow-up study.

J. Alijotas-Reig, J. Ordi‐Ros, S. Buján, 2021, Rheumatology.

Safety and efficacy of home intravenous antimicrobial infusion therapy in older patients: a comparative study with younger patients

J. Pérez-López, J. Pardos-Gea, A. San José Laporte, 2008, International journal of clinical practice.

Beta2-glycoprotein I gene polymorphisms Val247Leu and Trp316Ser in Spanish patients with primary antiphospholipid syndrome

M. Vilardell‐Tarrés, J. Castro-Marrero, E. Balada, 2012, Rheumatology International.

Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review

J. Alijotas-Reig, F. Miró-Mur, E. Esteve-Valverde, 2022, Journal of clinical medicine.

Anti-PDGFR-α antibodies measured by non-bioactivity assays are not specific for systemic sclerosis

V. Fonollosa-Plá, M. Vilardell‐Tarrés, C. Simeón-Aznar, 2008, Annals of the rheumatic diseases.

Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome

J. Alijotas-Reig, F. Miró-Mur, D. Roggenbuck, 2022, International journal of molecular sciences.

Management of acquired hemophilia A: results from the Spanish Registry.

J. Rodriguez-Garcia, M. Álvarez‐Román, M. Mingot-Castellano, 2021, Blood advances.

Acquired haemophilia A. First line treatment with calcineurin inhibitors and steroid pulses: a 10‐year follow‐up study

M. Vilardell‐Tarrés, C. Altisent, R. Parra, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Diagnostic delay in acquired haemophilia: Analysis of causes and consequences in a 20‐year Spanish cohort

C. Altisent, R. Parra, J. Pardos-Gea, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

[Home intravenous antibiotic therapy of empyema and lung abscess: safety and efficacy].

J. Pérez-López, J. Pardos-Gea, A. San José Laporte, 2011, Enfermedades infecciosas y microbiologia clinica.

Erythromelalgia in a patient treated with penicillin

J. Pardos-Gea, A. Lora-Cabral, 2012 .

A. Fernández-Codina, F. Martínez-Valle, B. Pinilla, 2015, Medicine.

Protein Z levels and anti-protein Z antibodies in patients with arterial and venous thrombosis.

M. Vilardell, E. Balada, J. Ordi‐Ros, 2008, Thrombosis research.

Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic review.

J. Alijotas-Reig, F. Miró-Mur, E. Esteve-Valverde, 2021, Autoimmunity reviews.

Protein Z and atherosclerotic disease: a less close relationship than though

J. Pardos-Gea, 2017, Journal of Thrombosis and Thrombolysis.

Severe bleeding diathesis as onset of light-chain amyloidosis: combined excessive fibrinolysis and acquired von Willebrand disease in a young patient

J. Pardos-Gea, Joana Marques-Soares, Fernanda Martinez, 2022, Blood Coagulation and Fibrinolysis.

Acquired von Willebrand syndrome in a patient with small lymphocytic lymphoma and Sjögren's syndrome: which associated condition should be prioritized?

F. Bosch, P. Abrisqueta, J. Pardos-Gea, 2019, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[Intravenous antibiotic treatment in a hospital based home care unit. Predictors of hospital readmission].

J. Pardos-Gea, A. San José Laporte, M. Vilardell Tarrés, 2008, Medicina clinica.

Chronic intestinal pseudo-obstruction associated with biliary tract dilatation in a patient with systemic lupus erythematosus

M. Vilardell, E. Balada, J. Ordi‐Ros, 2005, Lupus.

Acquired haemophilia A: Successful treatment with immunosuppression, methylprednisolone pulses and oral cyclosporin

M. Vilardell, C. Altisent, E. Balada, 2006, Thrombosis and Haemostasis.

Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group.

G. Espinosa, A. Tincani, J. Alijotas-Reig, 2023, Placenta.

Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository

M. Petri, T. Ortel, Quanzhen Li, 2023, Arthritis & rheumatology.

Damage measured by damage index for antiphosphlipid syndrome in antiphospholipid antibody-positive patients included in APS ACTION Registry.

M. Petri, T. Ortel, S. Sciascia, 2023, Rheumatology.

Anti-PDGFR-α antibodies measured by non-bioactivity assays are not specific for systemic sclerosis

V. Fonollosa-Plá, C. Simeón-Aznar, E. Balada, 2008, Annals of the rheumatic diseases.

Echocardiography at diagnosis of antiphospholipid syndrome provides prognostic information on valvular disease evolution and identifies two subtypes of patients

A. Evangelista, M. Vilardell, E. Balada, 2010, Lupus.